Navigation Links
Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
Date:3/17/2008

ter of this year."

About RDEA806

RDEA806 is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) for the potential treatment of HIV infection. Based on preclinical and clinical studies to-date, Ardea believes that RDEA806 may have important competitive advantages. These include the potential for potent antiviral activity against a wide range of HIV viral isolates, including those that are resistant to efavirenz (SUSTIVA(R)) and other currently available NNRTIs; a high genetic barrier to resistance; the potential to be administered in a patient-friendly, oral dosing regimen; limited pharmacokinetic interactions with other drugs; and the ability to be co-formulated with other HIV antiviral drugs.

Conference Call Details

To participate in tomorrow's live call by telephone, please dial 877-440-5786 from the U.S. or +1-719-325-4862 for international callers. In addition, the live conference call is being webcast and can be accessed on the "News & Events" page of the Company's website at http://www.ardeabio.com. A replay will also be available on Ardea's website and by telephone for 14 days following the live presentation. In the U.S., please dial 888-203-1112 or +1-719-457-0820 for international callers and, when prompted, enter passcode 8779421.

About Ardea Biosciences, Inc.

Ardea Biosciences, of San Diego, California, is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout. The Company has two product candidates in clinical development and several others in preclinical development. Ardea's most advanced clinical development candidate is RDEA806, a non-nucleoside reverse transcriptase inhibitor (NNRTI), which is in a Phase 2a study for the treatment of HIV. In addition, the Company is investigating RDEA806 for the treatment of gout. The Company's lead
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
2. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
7. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
8. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
9. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
10. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
11. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Texas , Aug. 21, 2014  Vermillion, Inc. ... focused on gynecologic cancers and women,s health, has appointed ... Sales and Managed Markets. Ms. Bauzon has ... and expanding payer coverage for laboratory services companies. She ... recently with PerkinElmer, Inc., where she held the position ...
(Date:8/21/2014)...  eRelevance Corporation ( www.erelevancecorp.com ), a progressive ... has completed integration with Nextech, a popular Electronic ... Dermatology practices. "Integration allows our service ... using Nextech," stated Bob Fabbio , co-founder ... the EMR we are able to automatically target ...
(Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe ... Hartley , Managing Partner and Healthcare Industry Group Leader, ... 100, which recognizes the most inspiring people in the ... leaders in research and development, marketing, technology, creativity, strategy ... in 2006 as a partner in its leading Rosetta ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Shannon Hartley Shines in PharmaVOICE 100 2
... Watson Pharmaceuticals, Inc. (NYSE: WPI ... Inc., filed an Abbreviated New Drug Application (ANDA) ... seeking approval to market Norethindrone Acetate/Ethinyl Estradiol and Ethinyl ... mg and 75 mg. Watson,s ANDA product is ...
... 2012 UCB, Inc., a leading biopharmaceutical company dedicated ... central nervous system and immunological disorders, is marking Digestive ... its commitment to improving the lives of patients with ... year,s DDW meeting. "DDW is an ...
Cached Medicine Technology:Watson Confirms Lo Loestrin® Fe Patent Challenge 2Watson Confirms Lo Loestrin® Fe Patent Challenge 3UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 2UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 3UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 4
(Date:8/21/2014)... The W. Montague Cobb/ NMA Health ... voice in the elimination of health disparities, honored ... 112th National Medical Association’s (NMA) Annual Convention and ... Ruffin, Ph.D, former Director of the National Institute ... career and innovations have had a significant impact ...
(Date:8/21/2014)... Rockville, MD (PRWEB) August 21, 2014 ... Pediatrics reported a 63% increase in disability associated with ... along with a more than 15% increase in disability ... of early intervention for rising numbers of children who ... Speech-Language-Hearing Association (ASHA). , On a broader ...
(Date:8/21/2014)... To sexually objectify a woman is to focus on ... sexual pleasure rather than viewing her as a complete ... long been considered a problem in the media, how ... in Psychology of Women Quarterly , a SAGE ... body is related to higher incidents of sexual pressure ...
(Date:8/21/2014)... Aug. 21, 2014 Researchers in the United ... cataracts can quickly and accurately diagnose a number of ... study published online today in Ophthalmology ... Using a single test, doctors were able to ... their mutations reducing the time and money spent on ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... blood thinner caused patients to suffer uncontrollable internal bleeding ... courts, Bernstein Liebhard LLP reports. According to court documents, ... in U.S. District Court, Easter District of New York ... due to a bleeding event that was allegedly caused ...
Breaking Medicine News(10 mins):Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3Health News:Objectification in romantic relationships related to sexual pressure and coercion 2Health News:New DNA test for diagnosing diseases linked to childhood blindness 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 3Health News:Xarelto Lawsuits Mount With New Filing in New York Federal Court, Bernstein Liebhard LLP Reports 4
... , FARMINGDALE, N.Y., Sept. 2 Misonix, ... invasive ultrasonic medical device technology, which in Europe is used ... health conditions, today announced the restructuring and expansion of its ... created; one for sales and service of the Sonablate(R) 500 ...
... COLO Research published in the September 2009 issue of ... an individual,s quality of life prior to treatment can help ... cell lung cancer (NSCLC). For those with advanced stage ... months, with approximately one-third of patients surviving past the one ...
... models to comb through thousands of injury reports in ... automatically classify them based on specific words or phrases. ... causes of injuries so that efforts could be directed ... Mark Lehto, an associate professor in Purdue University,s School ...
... ... in Chicago, IL USA offers two for one deal on summits. Also book your ... ... three weeks until Biopolymers Symposium 2009 conference and exhibit, taking place at the Embassy Suites ...
... , , , ... NBIX ) announced today that Kevin Gorman, President and Chief ... Partners Healthcare Conference in Boston. , , The ... Time (ET)/6:45 a.m. Pacific Time (PT). The presentation will be simultaneously ...
... occur before 65, study finds, many younger patients not ... Stroke could be affecting Americans earlier in life than ... no longer an affliction of old age," said lead ... and neurology and investigator for the Cognitive Rehabilitation Research ...
Cached Medicine News:Health News:Misonix Restructures and Expands Sales Organization in Europe 2Health News:Misonix Restructures and Expands Sales Organization in Europe 3Health News:Misonix Restructures and Expands Sales Organization in Europe 4Health News:New computer models aim to classify, help reduce injury accidents 2Health News:Biopolymers Symposium 2009 Offers Two for One Deal: Attend Retailers Scorecard Seminar and Attend the EcoLabeling Summit Free 2Health News:Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2Health News:Stroke May Be Striking at a Younger Age 2Health News:Stroke May Be Striking at a Younger Age 3
... with a 10-foot, kink-resistant cord for easier, ... electrosurgical pencils are the only product on ... non-stick tips allowing surgeons to make cleaner ... CLEAN PTFE coating is proven to last ...
... it maximizes use by allowing two ... while the third lamp is reserved ... in mind, it includes universal turrets ... excellent choice for hospital operating rooms ...
... The patented Applied Fiberoptics Gemini surgical headlight ... The headlight is durable and ultra-low-profile and ... closely without the annoying "rams effect." The ... nylon, is designed to sit low on ...
... use of some micro vascular clamps can ... With use, Stainless steel changes its elasticity, ... that pressures above 30g/mm2 may be associated ... from titanium which does not change its ...
Medicine Products: